President of drug company indicted for accepting more than $450,000 in bribes from supplier

TAMPA — An Odessa businessman and his Orlando business partner have been indicted for conspiracy to solicit and receive kickbacks and bribes.

Odessa resident Thomas Mollick, 79, and Martin Krytus, 55, face 15 years in prison if convicted and could have to forfeit assets.

Mollick co-founded and is president of RX Development and Krytus was the company’s vice president. The company, according to its website, is “a professional medication dispensing management company (that) assists doctors in implementing an all-inclusive point-of-care pharmaceutical program that delivers lasting results while improving billing and collections.”

As executives, prosecutors charge that between January 2012 and March 2017 the pair oversaw the creation and implementation of RX Development's in-office drug dispensing program. In their roles they selected the company’s wholesale drug supplier.

According to a press release from the U.S. Attorney's office announcing the indictment, the pair solicited a California-based supplier identified as Business #1 to make kickback payments to Mollick Enterprises Inc., a separate business Mollick was president of. According to the indictment, the company was told that in order to do business with RX Development it had to pay “a kickback of 10% of the total cost of drugs ordered by RXD's health care provider clients.”

Krytus, the indictment alleges, received a portion of the kickbacks from Mollick Enterprises, which is based in Pinellas County.

According to the indictment, Business #1 paid more than $450,000 in bribes in a series of 10 payments.

Mollick is still with the company and, according to a receptionist, was not in the office Monday March 28. It is unclear if Krytus is still employed.